(Q78124754)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446869%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

title

Treatment of early seropositive rheumatoid arthritis with minocycline: four-year followup of a double-blind, placebo-controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446869%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference

seropositive rheumatoid arthritis

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

1 reference

O'Dell JR

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446869%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Paulsen G

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446869%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Haire CE

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446869%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Blakely K

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446869%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Palmer W

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446869%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Wees S

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446869%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Eckhoff PJ

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446869%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Klassen LW

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446869%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Churchill M

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446869%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Doud D

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446869%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Weaver A

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446869%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Moore GF

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446869%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

publication date

1 August 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446869%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

published in

Arthritis and Rheumatism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446869%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446869%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446869%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

page(s)

1691-1695

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446869%20AND%20SRC:MED&resulttype=core&format=json

Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial

11 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1691%3A%3AAID-ANR18%3E3.0.CO%3B2-S

Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1691%3A%3AAID-ANR18%3E3.0.CO%3B2-S

Tetracyclines in the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1691%3A%3AAID-ANR18%3E3.0.CO%3B2-S

Tetracyclines may be therapeutically beneficial in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1691%3A%3AAID-ANR18%3E3.0.CO%3B2-S

The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1691%3A%3AAID-ANR18%3E3.0.CO%3B2-S

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1691%3A%3AAID-ANR18%3E3.0.CO%3B2-S

Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1691%3A%3AAID-ANR18%3E3.0.CO%3B2-S

Preliminary criteria for clinical remission in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1691%3A%3AAID-ANR18%3E3.0.CO%3B2-S

Treatment of destructive arthritic disorders with MMP inhibitors. Potential role of tetracyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1691%3A%3AAID-ANR18%3E3.0.CO%3B2-S

Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1691%3A%3AAID-ANR18%3E3.0.CO%3B2-S

Low dose doxycycline inhibits pyridinoline excretion in selected patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1691%3A%3AAID-ANR18%3E3.0.CO%3B2-S

Anti-collagenolytic mechanism of action of doxycycline treatment in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1691%3A%3AAID-ANR18%3E3.0.CO%3B2-S

Growth factor regulation of chondrocyte integrins. Differential effects of insulin-like growth factor 1 and transforming growth factor beta on alpha 1 beta 1 integrin expression and chondrocyte adhesion to type VI collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1691%3A%3AAID-ANR18%3E3.0.CO%3B2-S

Intestinal flora in early rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1691%3A%3AAID-ANR18%3E3.0.CO%3B2-S

Sequential study of bacterial antibody levels and faecal flora in rheumatoid arthritis patients taking sulphasalazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1691%3A%3AAID-ANR18%3E3.0.CO%3B2-S

Effects of sulphasalazine on faecal flora in patients with rheumatoid arthritis: a comparison with penicillamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1691%3A%3AAID-ANR18%3E3.0.CO%3B2-S

Processing of tumour necrosis factor-α precursor by metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1691%3A%3AAID-ANR18%3E3.0.CO%3B2-S

Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1691%3A%3AAID-ANR18%3E3.0.CO%3B2-S

10.1002/1529-0131(199908)42:8<1691::AID-ANR18>3.0.CO;2-S

21 January 2018

Identifiers

DOI

0 references

1 reference